Cord Partners is a fully owned subsidiary of Cord Blood America, and it maintains same mission: to provide each and every family the opportunity to invest in their future health and the promise of regenerative medicine. The company accomplishes this mission by providing reliable, affordable, and – most importantly – accredited services to store cord blood stem cells. The company has been proving the success of this practice for more than ten years, and in that time has perfected its collection, processing, and storage techniques.
Cord Partners is committed to ensuring that the potentially lifesaving services offered are available to each and every family who wishes to participate in its programs. The company ensures this by offering a number of payment choices to meet the various financial needs of customers. These payment options include discounts and incentives for people paying up front, short and long-term interest-free monthly plans, and even a no-money down, annual plan which is the first of its kind in the cord blood industry.
The President and CEO of Cord Partners parent company, Cord Blood America, is Mr. Matthew Schissler. Due to the controversial nature of the company’s business, Schissler has spent a lot of time defending the company’s lifesaving technology. He has been quoted by the media for such strong, supporting statements as: “Stem cells are used today in the treatment of leukemia, breast cancer, lymphoma, Hodgkin’s Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders.” He has also stated, “As stem cell transplants become routine, they may be used to fight many other cancers, viruses and genetic disorders.”
Cord Blood America Incorporated was founded in Los Angeles, California in 2003, and has not only been collecting, testing and processing umbilical cords in the United States, but has also been actively engaging in advertising through print, radio and television for further support of its cause. In 2004, the company generated only $752,000 in revenues, which by 2005 had tripled to over $2.28 million. This steady increase has continued, as the company recorded revenues of $3.33 million in 2006 and is on pace to finish its 2007 fiscal year with nearly $8 million in total revenues.
Let us hear your thoughts: Cord Blood America Inc. Message Board